126 related articles for article (PubMed ID: 1571544)
1. Binding of fibrin fragments to one-chain and two-chain tissue-type plasminogen activator.
Hasan AA; Chang WS; Budzynski AZ
Blood; 1992 May; 79(9):2313-21. PubMed ID: 1571544
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.
Stewart RJ; Fredenburgh JC; Weitz JI
J Biol Chem; 1998 Jul; 273(29):18292-9. PubMed ID: 9660794
[TBL] [Abstract][Full Text] [Related]
3. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
Weitz JI; Leslie B; Ginsberg J
J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
[TBL] [Abstract][Full Text] [Related]
4. Binding of tissue-type plasminogen activator to fibrinogen fragments.
Bosma PJ; Rijken DC; Nieuwenhuizen W
Eur J Biochem; 1988 Mar; 172(2):399-404. PubMed ID: 3127207
[TBL] [Abstract][Full Text] [Related]
5. Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator. A potential mechanism for enhancing the fibrin specificity of tissue plasminogen activator.
Stewart RJ; Fredenburgh JC; Rischke JA; Bajzar L; Weitz JI
J Biol Chem; 2000 Nov; 275(47):36612-20. PubMed ID: 10970891
[TBL] [Abstract][Full Text] [Related]
6. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
Liu JN; Gurewich V
J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
[TBL] [Abstract][Full Text] [Related]
8. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
Bakker AH; Nieuwenbroek NM; Verheijen JH
Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
[TBL] [Abstract][Full Text] [Related]
9. Effects of intact fibrin and partially plasmin-degraded fibrin on kinetic properties of one-chain tissue-type plasminogen activator.
Fischer BE; Will H
Biochim Biophys Acta; 1990 Oct; 1041(1):48-54. PubMed ID: 2145980
[TBL] [Abstract][Full Text] [Related]
10. Differences between binding of one-chain and two-chain tissue plasminogen activators to non-cross-linked and cross-linked fibrin clots.
Husain SS; Hasan AA; Budzynski AZ
Blood; 1989 Aug; 74(3):999-1006. PubMed ID: 2502209
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of fibrinogen and fibrin products and isolated peptide chains on the fibrin-mediated stimulation of plasminogen activation by tissue-type plasminogen activator, and on the fibrin-dependent enhancement of the amidolytic activity of one-chain tissue-type plasminogen activator.
Fischer B
Biol Chem Hoppe Seyler; 1990 Nov; 371(11):1067-75. PubMed ID: 2128181
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen fragments K 1-3 and K 5 bind to different sites in fibrin fragment DD.
Grinenko TV; Kapustianenko LG; Yatsenko TA; Yusova OI; Rybachuk VN
Ukr Biochem J; 2016; 88(3):36-45. PubMed ID: 29235323
[TBL] [Abstract][Full Text] [Related]
13. Interaction of plasminogen and fibrin in plasminogen activation.
Wu HL; Chang BI; Wu DH; Chang LC; Gong CC; Lou KL; Shi GY
J Biol Chem; 1990 Nov; 265(32):19658-64. PubMed ID: 2174048
[TBL] [Abstract][Full Text] [Related]
14. Identification of the mechanism responsible for the increased fibrin specificity of TNK-tissue plasminogen activator relative to tissue plasminogen activator.
Stewart RJ; Fredenburgh JC; Leslie BA; Keyt BA; Rischke JA; Weitz JI
J Biol Chem; 2000 Apr; 275(14):10112-20. PubMed ID: 10744692
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.
Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
J Biol Chem; 1988 Dec; 263(35):19083-91. PubMed ID: 3143723
[TBL] [Abstract][Full Text] [Related]
16. Tissue-type plasminogen activator and its substrate Glu-plasminogen share common binding sites in limited plasmin-digested fibrin.
de Vries C; Veerman H; Koornneef E; Pannekoek H
J Biol Chem; 1990 Aug; 265(23):13547-52. PubMed ID: 2143185
[TBL] [Abstract][Full Text] [Related]
17. Importance of the interaction between plasminogen and fibrin for plasminogen activation by tissue-type plasminogen activator.
Dunn FW; Deguchi K; Soria J; Soria C; Lijnen HR; Tobelem G; Caen J
Thromb Res; 1984 Nov; 36(4):345-51. PubMed ID: 6543039
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a fusion protein consisting of amino acids 1 to 263 of tissue-type plasminogen activator and amino acids 144 to 411 of urokinase-type plasminogen activator.
Nelles L; Lijnen HR; Collen D; Holmes WE
J Biol Chem; 1987 Aug; 262(22):10855-62. PubMed ID: 2956260
[TBL] [Abstract][Full Text] [Related]
19. Fibrin structures during tissue-type plasminogen activator-mediated fibrinolysis studied by laser light scattering: relation to fibrin enhancement of plasminogen activation.
Bauer R; Hansen SL; Jones G; Suenson E; Thorsen S; Ogendal L
Eur Biophys J; 1994; 23(4):239-52. PubMed ID: 7805626
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of fibrin binding on the biochemical properties of single-chain tissue-type plasminogen activator (t-PA) and single-chain chimeric plasminogen activator (t-PA/scu-PA).
Fischer BE
Blood Coagul Fibrinolysis; 1992 Feb; 3(1):39-46. PubMed ID: 1320415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
